anx_I__cpt_22__cpt_1__cpt_2__text_4

Regulation (EU) No 1291/2013 of the European Parliament and of the Council of 11 December 2013 establishing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020) and repealing Decision No 1982/2006/EC Text with EEA relevance · European Union

To maximise the impact of Union level actions, support will be provided to the full spectrum of research, development and innovation activities from basic research through translation of knowledge on disease to new therapeutics, to large trials, piloting and demonstration actions, by mobilising private investment; to public and pre-commercial procurement for new products, services and scalable solutions, which are, when necessary, interoperable and supported by defined standards and/or common guidelines. This coordinated, European effort will increase the scientific capabilities in health research and contribute to the ongoing development of the ERA. It will also interface, as and when appropriate, with activities developed in the context of the Health for Growth Programme, the Joint Programming Initiatives, including "Neurodegenerative Disease Research", "A Healthy Diet for a Healthy Life", "Antimicrobial resistance" and "More Years, Better Lives", and the European Innovation Partnership on Active and Healthy Ageing.

← anx_I__cpt_22__cpt_1__cpt_2__text_3 · All articles · anx_I__cpt_22__cpt_1__cpt_2__text_5 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-03 · Text as adopted (Official Journal); later amendments are not incorporated in this text.